Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 108

1.

Appropriate dosing of adjuvant radioactive iodine for differentiated thyroid cancer.

Bohinc BN, Perkins JM.

Curr Opin Oncol. 2014 Jan;26(1):31-5. doi: 10.1097/CCO.0000000000000039. Review.

PMID:
24225414
[PubMed - indexed for MEDLINE]
2.

Radioactive iodine therapy.

Lee SL.

Curr Opin Endocrinol Diabetes Obes. 2012 Oct;19(5):420-8. doi: 10.1097/MED.0b013e328357fa0c. Review.

PMID:
22914564
[PubMed - indexed for MEDLINE]
3.

Decreasing the dose of radioiodine for remnant ablation does not increase structural recurrence rates in papillary thyroid carcinoma.

Kruijff S, Aniss AM, Chen P, Sidhu SB, Delbridge LW, Robinson B, Clifton-Bligh RJ, Roach P, Gill AJ, Learoyd D, Sywak MS.

Surgery. 2013 Dec;154(6):1337-44; discussion 1344-5.

PMID:
24383104
[PubMed - indexed for MEDLINE]
4.

Recombinant human thyroid-stimulating hormone to stimulate 131-I uptake for remnant ablation and adjuvant therapy.

Sabra MM, Tuttle RM.

Endocr Pract. 2013 Jan-Feb;19(1):149-56. doi: 10.4158/EP12278.RA. Review.

PMID:
23186980
[PubMed - indexed for MEDLINE]
5.

Radioiodine remnant ablation: current indications and dosing regimens.

Haugen BR.

Endocr Pract. 2012 Jul-Aug;18(4):604-10. doi: 10.4158/EP12117.CO. Review.

PMID:
22849876
[PubMed - indexed for MEDLINE]
6.

Well-differentiated thyroid carcinoma: the role of post-operative radioactive iodine administration.

Patel SS, Goldfarb M.

J Surg Oncol. 2013 May;107(6):665-72. doi: 10.1002/jso.23295. Epub 2012 Nov 28. Review.

PMID:
23192391
[PubMed - indexed for MEDLINE]
7.

Radioactive iodine administered for thyroid remnant ablation following recombinant human thyroid stimulating hormone preparation also has an important adjuvant therapy function.

Tuttle RM, Lopez N, Leboeuf R, Minkowitz SM, Grewal R, Brokhin M, Omry G, Larson S.

Thyroid. 2010 Mar;20(3):257-63. doi: 10.1089/thy.2009.0401.

PMID:
20187781
[PubMed - indexed for MEDLINE]
8.

Rising incidence of second cancers in patients with low-risk (T1N0) thyroid cancer who receive radioactive iodine therapy.

Iyer NG, Morris LG, Tuttle RM, Shaha AR, Ganly I.

Cancer. 2011 Oct 1;117(19):4439-46. doi: 10.1002/cncr.26070. Epub 2011 Mar 22.

PMID:
21432843
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Post-surgical thyroid ablation with low or high radioiodine activities results in similar outcomes in intermediate risk differentiated thyroid cancer patients.

Castagna MG, Cevenini G, Theodoropoulou A, Maino F, Memmo S, Claudia C, Belardini V, Brianzoni E, Pacini F.

Eur J Endocrinol. 2013 Jun 1;169(1):23-9. doi: 10.1530/EJE-12-0954. Print 2013 Jul.

PMID:
23594687
[PubMed - indexed for MEDLINE]
Free Article
10.

Radioactive iodine ablation does not prevent recurrences in patients with papillary thyroid microcarcinoma.

Kim HJ, Kim NK, Choi JH, Kim SW, Jin SM, Suh S, Bae JC, Min YK, Chung JH, Kim SW.

Clin Endocrinol (Oxf). 2013 Apr;78(4):614-20. doi: 10.1111/cen.12034.

PMID:
22957654
[PubMed - indexed for MEDLINE]
11.

Recombinant human thyroid stimulating hormone-assisted radioactive iodine remnant ablation in thyroid cancer patients at intermediate to high risk of recurrence.

Hugo J, Robenshtok E, Grewal R, Larson S, Tuttle RM.

Thyroid. 2012 Oct;22(10):1007-15. doi: 10.1089/thy.2012.0183. Epub 2012 Aug 8.

PMID:
22873801
[PubMed - indexed for MEDLINE]
12.

Clinical outcomes following empiric radioiodine therapy in patients with structurally identifiable metastatic follicular cell-derived thyroid carcinoma with negative diagnostic but positive post-therapy 131I whole-body scans.

Sabra MM, Grewal RK, Tala H, Larson SM, Tuttle RM.

Thyroid. 2012 Sep;22(9):877-83. doi: 10.1089/thy.2011.0429. Epub 2012 Jul 24.

PMID:
22827641
[PubMed - indexed for MEDLINE]
13.

Selective use of RAI for ablation and adjuvant therapy after total thyroidectomy for differentiated thyroid cancer: a practical approach to clinical decision making.

Tuttle RM, Sabra MM.

Oral Oncol. 2013 Jul;49(7):676-83. doi: 10.1016/j.oraloncology.2013.03.444. Epub 2013 Apr 16. Review.

PMID:
23601564
[PubMed - indexed for MEDLINE]
14.

Association between excessive urinary iodine excretion and failure of radioactive iodine thyroid ablation in patients with papillary thyroid cancer.

Sohn SY, Choi JY, Jang HW, Kim HJ, Jin SM, Kim SW, Suh S, Hur KY, Kim JH, Chung JH, Kim SW.

Thyroid. 2013 Jun;23(6):741-7. doi: 10.1089/thy.2012.0136.

PMID:
23205883
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Radioiodine lobar ablation as an alternative to completion thyroidectomy in patients with differentiated thyroid cancer.

Bal CS, Kumar A, Pant GS.

Nucl Med Commun. 2003 Feb;24(2):203-8.

PMID:
12548045
[PubMed - indexed for MEDLINE]
16.
17.

Effects of different doses of radioactive iodine for remnant ablation on successful ablation and on long-term recurrences in patients with differentiated thyroid carcinoma.

Kim EY, Kim TY, Kim WG, Yim JH, Han JM, Ryu JS, Hong SJ, Yoon JH, Gong G, Kim WB, Shong YK.

Nucl Med Commun. 2011 Oct;32(10):954-9. doi: 10.1097/MNM.0b013e32834956ec.

PMID:
21849927
[PubMed - indexed for MEDLINE]
18.

Salivary gland side effects commonly develop several weeks after initial radioactive iodine ablation.

Grewal RK, Larson SM, Pentlow CE, Pentlow KS, Gonen M, Qualey R, Natbony L, Tuttle RM.

J Nucl Med. 2009 Oct;50(10):1605-10. doi: 10.2967/jnumed.108.061382. Epub 2009 Sep 16.

PMID:
19759114
[PubMed - indexed for MEDLINE]
Free Article
19.

Incidence of radiation thyroiditis and thyroid remnant ablation success rates following 1110 MBq (30 mCi) and 3700 MBq (100 mCi) post-surgical 131I ablation therapy for differentiated thyroid carcinoma.

Cherk MH, Kalff V, Yap KS, Bailey M, Topliss D, Kelly MJ.

Clin Endocrinol (Oxf). 2008 Dec;69(6):957-62. doi: 10.1111/j.1365-2265.2008.03276.x. Epub 2008 Apr 12.

PMID:
18419785
[PubMed - indexed for MEDLINE]
20.

Undetectable thyroglobulin after total thyroidectomy in patients with low- and intermediate-risk papillary thyroid cancer--is there a need for radioactive iodine therapy?

Ibrahimpasic T, Nixon IJ, Palmer FL, Whitcher MM, Tuttle RM, Shaha A, Patel SG, Shah JP, Ganly I.

Surgery. 2012 Dec;152(6):1096-105. doi: 10.1016/j.surg.2012.08.034.

PMID:
23158181
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk